Target intelligence / Profile preview

RNA, U2 small nuclear 15, pseudogene (RNU2-15P)

Target
RNU2-15P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RNA, U2 small nuclear 15, pseudogene (RNU2-15P) is annotated as a human pseudogene corresponding to U2 small nuclear RNA (snRNA)[4]. U2 snRNA is a core component of the spliceosome and is essential for pre-mRNA splicing[2][3], but RNU2-15P itself is a pseudogene, meaning it is a non-functional genomic sequence related to U2 snRNA but does not produce a functional RNA product or protein[4]. Pseudogenes such as RNU2-15P do not play a direct biological role in cellular processes and are generally not involved in disease or considered therapeutic targets[4]. There is no evidence that RNU2-15P interacts with drugs, serves as a biomarker, or presents safety concerns; nor is there documentation of involvement in human disease or regulated biological pathways. Mutation or expression changes in canonical U2 snRNA genes can be pathogenic[3], but this is not applicable to RNU2-15P.

Other names
RNU2-15PRNA, U2 small nuclear 15, pseudogene
02

Mechanism of action

Not applicable

03

Biological functions

None documented (pseudogene; does not encode a functional product)
04

Disease associations

None established
05

Safety considerations

None documented
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, U2 small nuclear 15, pseudogene (RNU2-15P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 15, pseudogene (RNU2-15P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call